VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > OH OH TOO MUCH LUBE

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 14, 2021 1:58am

103 Views

Post# 34227780

RE:RE:RE:RE:RE:RE:OH OH TOO MUCH LUBE

banderas1976 wrote: Totally wrong. Current scans 2D /3D are already rolling

should be 4D I guess!!!

Are you saying there is something wrong with this supposed blog or letter which is not dated or verified and not on the website (last I looked).

Wouldn't surprise me as it seems to be out in left field from what we have been given and it also seems strange that no one else has spoken up -- i.e. all those letter recipients.

<< Previous

Bullboard Posts

Next >>

DRI Healthcare stock drops 28% after executive changes